Prognostic Factors in the Radical Nonsurgical Treatment of Stage IIIB Non–Small-Cell Lung Cancer
Paul Wheatley‐Price(University of Ottawa), Elham Sabri(Ottawa Hospital), Brian C. Healy(Evidence (Italy)), Jason Pantarotto(University of Ottawa), Robert M. MacRae(University of Ottawa), Scott A. Laurie(Ottawa Hospital)
Cited by 15
Related Papers
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
|Science|2022|2k
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
|The Lancet Oncology|2016|1.2k